Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM149PT
TNBC
Basal B
CGC-11047
Polyamine analogue
7917.018
uM
149.12370
996.38530
-0.6063 -1.0000 0.5784 0.3765
0.9415
2.8573
SUM149PT
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
7917.13
uM
2.12970
4.0810
-0.8198 -0.7773 1.4422 0.5773
0.9939
2.7649
SUM149PT
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9830.017
uM
2.21520
4.44660
-0.9393 -0.9447 1.5228 0.6009
0.9970
1.8576
SUM149PT
TNBC
Basal B
Dactolisib
PI3K
PI3K
11937.155
uM
inf
0.10026
0.5758 0.5108 1.8948 0.2623
0.6188
2.4784
SUM149PT
TNBC
Basal B
Dactolisib
PI3K
PI3K
10819.155
uM
0.48655
0.42552
0.1893 0.2442 5.0000 0.2523
0.9818
2.0561
SUM149PT
TNBC
Basal B
Dichloroacetate
PDK
PDK
13123.176
uM
inf
inf
0.6345 0.6345 0.0000 0.1874
0.1319
1.1020
SUM149PT
TNBC
Basal B
Disulfiram
Proteasome
Proteasome
13123.174
uM
inf
inf
-0.0732 -0.0732 0.0000 0.2459
0.2528
1.0408
SUM149PT
TNBC
Basal B
Docetaxel
TUBB
TUBB
9830.002
uM
0.00179
0.00180
-0.0390 -0.0047 2.1102 0.6781
0.950
1.9252
SUM149PT
TNBC
Basal B
Epirubicin
TOP2
TOP
9830.017
uM
0.25888
0.56835
-0.9769 -0.9014 1.3105 0.8282
0.9964
1.8576
SUM149PT
TNBC
Basal B
Erlotinib
EGFR
ErbB
7530.091
uM
4.56080
1.40830
0.2650 0.2207 0.4954 0.2313
0.9294
2.0794
SUM149PT
TNBC
Basal B
Etoposide
TOP2
TOP
7530.074
uM
4.22870
22.1520
-0.3573 -0.7406 0.5487 0.4231
0.9667
2.0964
SUM149PT
TNBC
Basal B
Everolimus
MTOR
MTOR
11937.164
uM
14.03820
27.25510
-0.6684 -1.0000 1.6559 0.2818
0.8982
2.5679
SUM149PT
TNBC
Basal B
Fascaplysin
CDK4
CDK
7530.085
uM
0.41679
0.65723
-0.8007 -0.7968 2.0924 0.5562
0.9982
2.1343
SUM149PT
TNBC
Basal B
FR180204
ERK1/2
MAPK
11937.161
uM
25.46940
113.63330
0.0245 -1.0000 0.7346 0.1916
0.9352
2.4516
SUM149PT
TNBC
Basal B
FR180204
ERK1/2
MAPK
10819.149
uM
20.60350
61.52680
0.2962 -1.0000 1.0042 0.0971
0.9784
2.0505
SUM149PT
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
11937.154
uM
20.66880
41.04130
0.1651 -1.0000 1.6016 0.1156
0.9368
2.5304
SUM149PT
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10819.154
uM
32.05760
34.71070
0.4426 -0.2426 4.9745 0.0447
0.9691
2.0680
SUM149PT
TNBC
Basal B
Gefitinib
EGFR
ErbB
7917.016
uM
11.890
154.46670
0.2744 -1.0000 0.4284 0.1553
0.9529
2.9532
SUM149PT
TNBC
Basal B
Gefitinib
EGFR
ErbB
9830.019
uM
2.08280
18.80720
-0.1896 -1.0000 0.4993 0.2513
0.9718
1.9053
SUM149PT
TNBC
Basal B
Geldanamycin
HSP90
HSP90
9830.012
uM
0.00575
0.00857
-0.6166 -0.6015 1.9785 1.1551
0.9977
1.8343
SUM149PT
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7917.075
uM
0.11826
0.23897
-0.0734 -0.1244 0.3158 0.6678
0.9308
3.0479
SUM149PT
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9830.011
uM
0.02184
0.04942
-0.2371 -0.2487 0.4944 0.7563
0.9404
2.0792
SUM149PT
TNBC
Basal B
Glycyl-H-1152
ROCK2
10819.15
uM
69.42850
464.22560
0.6339 -1.0000 0.5782 0.0678
0.9396
2.1256
SUM149PT
TNBC
Basal B
Glycyl-H-1152
ROCK2
11937.16
uM
84.87320
21.4970
0.5288 0.3549 0.9008 0.0794
0.9443
2.4144
SUM149PT
TNBC
Basal B
GM6001
MMP
MMP
7530.096
uM
211.7840
994.0430
0.7438 -0.5799 0.4980 0.0564
0.7339
2.1549